ARFXF News and Press, Amorfix Life Sciences Ltd From 06/19/19

ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board Canada NewsWire TORONTO and CAMBRIDGE, MA, June 19, 2019 Internationally recognized leader in neurodegenerative diseases to advise on programs selectively ta...

Noteworthy events during the week of June 16 - 22 for healthcare investors. More news on: ProMIS Neurosciences, Inc., Merck & Co., Inc., IQVIA Holdings Inc., Healthcare stocks news, , Read more ...

Neurodegenerative Diseases: New Insights and Therapeutic Opportunities to advance discussion about therapies for Alzheimer's disease among world's leading researchers TORONTO and CAMBRIDGE, MA , June 5, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biot...

TORONTO and CAMBRIDGE, MA , May 29, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative disea...

ProMIS Neurosciences ( OTCQB:ARFXF ) has identified several antibody candidates that selectively bind the toxic form of Tau and amyloid beta. More news on: ProMIS Neurosciences, Inc., Healthcare stocks news, Read more ...

ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau Canada NewsWire TORONTO and CAMBRIDGE, MA, May 28, 2019 Pipeline offers critical "one-two punch" in potential treatment arsenal for Alzheimer's disease ...

Company continues to show significant progress on developing highly selective antibodies targeting root cause of Alzheimer's and Parkinson's diseases and ALS TORONTO and CAMBRIDGE, MA , May 14, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotech...

ProMIS Neurosciences to Participate in the Think Equity Investor Conference Canada NewsWire TORONTO and CAMBRIDGE, MA, April 23, 2019 Company to showcase its innovative Alzheimer's, Parkinson's and ALS programs TORONTO and CAMBRIDGE, MA , April 23, 2019 /CNW/ - ProM...

The Canadian biotech sector might be one of the country’s best kept secrets in terms of market size and growth potential. Case in point, an industry report published in 2018 by BIOTECanada indicates the biotech industry is a top tier technology hub in the country and is projected ...

POINT ROBERTS, Wash. and DELTA, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Investorideas.com , a leading investor news resource covering biotech and pharma stocks releases a snapshot looking at the biopharmaceutical market and how monoclonal antibody research is gaining market ...